FDA Investigator Youkeun Kim
Youkeun Kim has inspections in 3 countries as of 09 Nov 2023. Youkeun Kim has collaborated with a combined 911 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
12
Last Inspection Date:
09 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
China,
India
Co-Investigator(s):
Ademola O Daramola,
Alan L Truong,
Alan P Kurtzberg,
Alice S Tsao,
Arsen Karapetyan,
Bryan A Galvez,
Bryan L Mcguckin,
Carla J Lundi,
Carr Sharpe,
Carrie A Hughes,
Caryn M Mcnab,
Crystal Monroy,
Diane Cvan Leeuwen,
Gary L Pierce,
Ivis Lnegron Torres,
Jacqueline S Warner,
Jane S Wernberg,
Jawaid Hamid,
Jennifer M Gogley,
Joel D Hustedt,
Joey V Quitania,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Joshua J Silvestri,
Katherine D Adams,
Kelley,
Kellia N Hicks,
Kelvin X Sanders,
Kham Phommachanh,
Lillian S Wu,
Marcus F Yambot,
Maxyne T Lam,
Michael A Charles,
Michael D Garcia,
Nicholas Fragedakis,
Nicholas L Hunt,
Parul M Patel,
Paul A Bonneau,
Peter E Baker,
Ramon A Hernandez,
Rochelle K Kimmel,
Rumany C Penn, PharmD,
Stephanie A Slater, MS,
Steven D Dittert,
Susan M Jackson,
Teresa T Cain,
Thomas J Arista,
Tiara M Brown,
Todd M Stankewicz,
Tracey T Duong,
Uttaniti Limchumroon (Tom),
Virgilio F Pacio, CSO
Youkeun Kim's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2022 | FDA 483 | COSMETIC LAB INC. - Form 483, 2022-08-03 |
September, 2022 | FDA 483 | Cosmetic Science Laboratories, LLC - Form 483, 2022-09-20 |
February, 2023 | FDA 483 | Elemental Herbs, Inc. - Form 483, 2023-02-03 |
November, 2022 | FDA 483 | Pharmedica USA, LLC - Form 483, 2022-11-07 |
June, 2023 | FDA 483 | ALS Group USA, Corp. - Form 483, 2023-06-05 |
July, 2023 | FDA 483 | GLAND PHARMA LIMITED - Form 483, 2023-07-14 |
June, 2022 | FDA 483 | Airgas Usa, LLC - Form 483, 2022-06-07 |
December, 2023 | FDA 483 | Den-Mat Holdings, LLC - Form 483, 2023-12-07 |
November, 2023 | FDA 483 | AVASOL LLC - Form 483, 2023-11-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more